Advertisement

Topics

Latest "Reckitt Benckiser, Inc., makers of LYSOL" News Stories

04:26 EST 17th December 2018 | BioPortfolio

Here are the most relevant search results for "Reckitt Benckiser, Inc., makers of LYSOL" found in our extensive news archives from over 250 global news sources.

More Information about Reckitt Benckiser, Inc., makers of LYSOL on BioPortfolio

In addition to our news stories we have dozens of PubMed Articles about Reckitt Benckiser, Inc., makers of LYSOL for you to read. Along with our medical data and news we also list Reckitt Benckiser, Inc., makers of LYSOL Clinical Trials, which are updated daily. BioPortfolio also has a large database of Reckitt Benckiser, Inc., makers of LYSOL Companies for you to search.

Showing "Reckitt Benckiser makers LYSOL" News Articles 1–25 of 597

Saturday 15th December 2018

The 10 biggest U.S. drug makers by sales together bought back ~ $52.4B of their own shares in the 1st 9 months of 2018 https://www.axios.com/republican-tax-law-spurs-more-drug-company-stock-buybacks-971d3a67-917c-4757-aadb-5b93caf5c20e.html …

The 10 biggest U.S. drug makers by sales together bought back ~ $52.4B of their own shares in the 1st 9 months of 2018 https://www.axios.com/republican-tax-law-spurs-more-drug-company-stock-buybacks-971d3a67-917c-4757-aadb-5b93caf5c20e.html …


Friday 14th December 2018

Misinformation is the only poison: the end of the Seralini Affair? (reposted from GMOinfo.eu)

By Beat Späth, Director for Agricultural Biotechnology at EuropaBio ( Reposting of this original)“Do you remember? These spectacular images of rats with invasive cancers (…). Exhibited on television. Broadcast in film, book, resounding articles. (…) But do you know that on December 10, the journal Toxicology Sciences published o

Study: New technologies leading to less traditional store checkouts

According to a study by Z


Thursday 13th December 2018

FDA pulls generics labeling proposed rule

Chronic Opioid Use Linked to Higher Healthcare Spending, Hospital Stays, AJAC Study Finds

Amid public health concerns about the risks of opioid overuse, a recent study in The American Journal of Accountable Care® (AJAC) shows increased economic burden on patients and payers when opioid therapy for noncancer pain continues beyond the initial prescription. Using data from commercial insurance claims of working-aged adults, new researc...

STAT Plus: FDA yanks controversial rule to allow generic makers to update product labels

The agency worried the rule could create “unintended consequences” by confusing patients and doctors.

Press Ganey White Paper Presents Consumerism Strategies for Brand Building and Market Share Growth

Patient experience insights drive marketing and transparency initiatives Press Ganey today released its white paper, Consumerism: The Role of Patient Experience in Brand Management and Patient Acquisition. Analyses of proprietary research from health care consumer decision makers finds that patient experience is a key predictor of brand loyalty ...

Wednesday 12th December 2018

This drug makers $4,100 brand-name automated naloxone injector is getting a generic version for a retail price of $178. https://buff.ly/2Qpm4XQ 

This drug makers $4,100 brand-name automated naloxone injector is getting a generic version for a retail price of $178. https://buff.ly/2Qpm4XQ 

Kratom Trade Association: Kratom Community Needs Less “Doomsday Rhetoric,” More Unified Approach in Order to Survive

“Time to Turn Down the Rhetoric and Step Up the Cooperation”: KTA Outlines Major Progress on Opposing Federal Scheduling of Kratom, State Bans, Import Restrictions, and Inferior/Adulterated Product. Kratom, the natural, coffee-like herb associated with better health and well-being, faces many challenges today and it has its best shot at survival if...

STAT Plus: This is only the latest setback for the company, one of India's largest drug makers. https://buff.ly/2C8E3sS 

STAT Plus: This is only the latest setback for the company, one of India's largest drug makers. https://buff.ly/2C8E3sS 

STAT Plus: Sun Pharma faces a new problem as Indian regulator probes whistleblower charges

This is only the latest setback for the company, one of India's largest drug makers.

Atlantic Ultraviolet Corporation is Pleased to Announce the Launch of an Application-Specific Page on Ultraviolet.com for Individuals who Experience Boil Water Alerts.

Atlantic Ultraviolet Corporation® has published their application-specific page for Boil Water Alerts. The Boil Water Alert page gives an easy-to-comprehend overview of UV-C usage for water disinfection during Boil Water Alerts. In addition to the overview page, a series of new sub-posts will be released that give more detailed information. HAUPPAUGE, N.Y. (PRWEB) December 12, 2018 Atlantic ...

Tuesday 11th December 2018

[Personal View] Epidemic preparedness: why is there a need to accelerate the development of diagnostics?

Global epidemics of infectious diseases are increasing in frequency and severity. Diagnostics are needed for rapid identification of the cause of the epidemic to facilitate effective control and prevention. Lessons learned from the recent Ebola virus and Zika virus epidemics are that delay in developing the right diagnostic for the right population at the right time has been a costly barrier to di...

Cura Partners, Inc. Hires Hotel Exec Angelo Lombardi as Chief Operating Officer

New COO Angelo Lombardi Joins Cura on its Mission to be the Leading Global Provider of Cannabis Oil Cura Partners, Inc., one of the largest cannabis companies in the world and maker of the Select brand, announces the appointment of Angelo Lombardi as Chief Operating Officer (COO). Lombardi joins Cura with more than 27 years in the hospitality in...

Driving Change for Diverse Patient Communities

SOURCE: Bristol-Myers Squibb Company DESCRIPTION:Editor’s note: In recognition of Global Patient Week, held annually across Bristol-Myers Squibb to celebrate the company’s patient-focused culture, we’re sharing how our People and Business Resource Groups are driving change for diverse patient populations.  When Priscilla Ko, a manager in the Bristol-Myers Squibb Foundation and member of th...

Monday 10th December 2018

Sesame Software Teams with Looker to Transform End-to-End CRM Data into Actionable Insights

SANTA CLARA, Calif., Dec. 10, 2018 /PRNewswire/ -- Sesame Software, makers of the Relational Junction Warehouse Builder, today announces the company has teamed with Looker, Read more...

Industry Advised To ‘Lawyer Up’ If Serialization Systems Don’t Comply With DSCSA

Drug makers must comply with draft FDA guidance on Drug Supply Chain Security Act serialization requirements that took effect Nov...   

Sunday 9th December 2018

At Least 16 Generic Drug Companies and 300 Drugs Target of Price-Fixing Investigation

It apparently began with a 2016 federal lawsuit. At that time, 20 state attorneys general filed a federal lawsuit alleging that six generic drug makers artificially inflated and manipulated prices for an antibiotic and an oral diabetes drug. The goal was to reduce competition.

Friday 7th December 2018

Opinion: Patent abuse by drug makers is one of the most influential drivers of rising drug prices. https://buff.ly/2L1VEpe 

Opinion: Patent abuse by drug makers is one of the most influential drivers of rising drug prices. https://buff.ly/2L1VEpe 

KTA Leaders: Kratom Safety is No Accident

Kratom Trade Association releases new Guide to Good Manufacturing Practices; pushes for adherence across Kratom industry The Kratom Trade Association (KTA), a leading non-profit trade organization representing manufacturers, distributors and retailers of natural Kratom products, today released its new “Guide to Good Manufacturing Practices (GMPs).”...

STAT Plus: Pharmalittle: Retail drug spending in the U.S. fell last year; Democrats eye patents to lower drug prices

Newly empowered Democrats in D.C. are hunting for bigger and bolder ways to lower drug prices and taking aim at the patents held by drug makers.

Who’s to blame in an autonomous car accident? A legal expert considers three scenarios

As car makers steam ahead in the driverless car race, lawmakers are being left in the dust – and one of...Read More... The post Who’s to blame in an autonomous car accident? A legal expert considers three scenarios appeared first on Pharmaceutical Technology.

FDA issues post-CRL meeting guidance for generics makers

In December 2018, the US Food and Drug Administration (FDA) published a new guidance document to assist generics makers with meetings with the agency following the issuance of a complete response letter (CRL).

Thursday 6th December 2018

Top-Down Demands on Primary Care Creating Medical Populism in Response to Burnout, AJMC® Commentary Says

The forces leading to detachment and depersonalization among burned-out primary care physicians are similar to the factors responsible for populist movements—the perception of a rigged system favoring a managerial elite, according to a commentary in the December issue of The American Journal of Managed Care. ® In a thought-provoking comme...

Cancer IVDs Could See Label Expansions Under New Guidance

US FDA is proposing to allow cancer IVD-makers to label their tests for certain types of cancers and their therapies...   


Advertisement
Quick Search
Advertisement
Advertisement

 

News Quicklinks